Deleterious de novo SHANK2 mutations have always been identified in a heterozygous state in patients with ASD, intellectual disability, attention deficit and hyperactivity disorder as well as language impairment, with one allele unaffected2–5. The gene discussed is SHANK2; the disease is Intellectual disability.